| Schedule of earnings per share |
The computation of earnings per share for the three and six months ended June 30, 2026 and 2025 are (in thousands, except per share and footnote amounts): | | | | | | | | | | | | | For the Three Months Ended June 30, | | For the Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | Basic EPS | | | | | | | | | | | | Numerator | | | | | | | | | | | | Net income | $ | 41,296 | | $ | 47,651 | | $ | 78,929 | | $ | 111,876 | Less: Earnings allocated to participating securities | | 4,113 | | | — | | | 7,955 | | | — | Net income available to common stockholders | | 37,184 | | | 47,651 | | | 70,974 | | | 111,876 | | | | | | | | | | | | | Denominator | | | | | | | | | | | | Weighted average shares outstanding | | 55,515 | | | 2,561 | | | 55,552 | | | 1,288 | Basic EPS | $ | 0.67 | | $ | 18.61 | | $ | 1.28 | | $ | 86.88 | | | | | | | | | | | | | Diluted EPS | | | | | | | | | | | | Numerator | | | | | | | | | | | | Net income available to common stockholders | $ | 37,184 | | $ | 47,651 | | $ | 70,974 | | $ | 111,876 | Reallocation of earnings from participating securities | | — | | | — | | | — | | | — | Net income available to common stockholders for diluted EPS | $ | 37,184 | | $ | 47,651 | | $ | 70,974 | | $ | 111,876 | | | | | | | | | | | | | Denominator | | | | | | | | | | | | Weighted average shares outstanding | | 55,515 | | | 2,561 | | | 55,552 | | | 1,288 | Weighted average effect of dilutive securities: | | | | | | | | | | | | Options(1) | | 4 | | | 282 | | | 2 | | | 142 | Nonvested restricted stock | | — | | | — | | | — | | | — | Number of shares used for diluted EPS computation | | 55,519 | | | 2,843 | | | 55,554 | | | 1,430 | Diluted EPS | $ | 0.67 | | $ | 16.76 | | $ | 1.28 | | $ | 78.26 |
| (1) | Options outstanding of 846,031 at June 30, 2026 were determined to be antidilutive and excluded from the dilutive EPS computation. |
|